Last $48.81 USD
Change Today +0.70 / 1.46%
Volume 254.2K
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

medidata solutions inc (MDSO) Snapshot

Open
$48.01
Previous Close
$48.11
Day High
$48.93
Day Low
$47.94
52 Week High
03/4/14 - $68.21
52 Week Low
05/7/14 - $32.10
Market Cap
2.7B
Average Volume 10 Days
260.1K
EPS TTM
$0.18
Shares Outstanding
55.2M
EX-Date
--
P/E TM
273.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIDATA SOLUTIONS INC (MDSO)

medidata solutions inc (MDSO) Related Bloomberg News

View More Bloomberg News

medidata solutions inc (MDSO) Related Businessweek News

No Related Businessweek News Found

medidata solutions inc (MDSO) Details

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company’s software solutions allow customers to increase the value of their clinical development by designing, planning, and managing study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. It offers Medidata Rave, a platform for capturing, managing, and reporting clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, which enhances the efficiency of clinical trial start-up; Medidata Insights, a business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Patient Cloud that captures patient-reported outcomes; Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and Medidata SQM, a set of cloud-based site quality management dashboards. In addition, it offers Medidata Coder that provides medical coding and synonym management solutions; Medidata Safety Gateway, which offers a solution for collecting and transmitting adverse events and related data from the EDC system; and Medidata Targeted SDV that provides auditable and scalable solutions, as well as offers hosting, support, and professional services. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, medical centers, contract research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

medidata solutions inc (MDSO) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $475.0K
Co-Founder, President, Director and President...
Total Annual Compensation: $475.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $330.0K
Chief Commercial Officer
Total Annual Compensation: $325.0K
Compensation as of Fiscal Year 2013.

medidata solutions inc (MDSO) Key Developments

TWi Biotechnology, Inc. Selects Medidata Clinical Cloud Based Platform to Advance Cutting-Edge Clinical Development

Medidata announced that its technology platform has been adopted by TWi Biotechnology, Inc. TWi Biotechnology selected the Medidata Clinical Cloud to enhance the speed, quality and productivity of its novel clinical study on metabolic disorders. TWi Biotechnology is focused on developing innovative new therapies for unmet medical needs in the areas of metabolism, orphan diseases and dermatology. To optimize a Phase-II study on metabolic disorders, TWi Biotechnology is implementing Medidata’s cloud-based technology for electronic data capture and management (Medidata Rave) and medical coding (Medidata Coder). In addition to enhancing productivity through real-time data entry, Medidata’s technology solutions are providing TWi Biotechnology with better clinical trial oversight that leads to earlier, more informed decision-making opportunities.

Medidata Solutions, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter and Full Year of 2015 and Revenue Guidance for the First Half and Second Half of 2015

Medidata Solutions, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. Total revenue for the fourth quarter of 2014 was $89.2 million, an increase of $14.6 million, or 20%, compared with $74.6 million in the fourth quarter of 2013. GAAP operating income was $9.1 million, compared with operating loss of $1.5 million in the fourth quarter of 2013. Non-GAAP operating income increased to $22.1 million, up 28% compared with $17.3 million a year ago. GAAP net income was $5.5 million, or $0.10 per diluted share, compared with $0.6 million, or $0.01 per diluted share, in the fourth quarter of 2013. Adjusted non-GAAP net income was $13.7 million, or $0.25 per diluted share, compared with $12.5 million, or $0.23 per diluted share, in the fourth quarter of 2013. Income before income taxes was $5.7 million against loss before income taxes of $5.0 million reported last year. EBITDA was a record $22.1 million, up 4% sequentially and 28% year-over-year. Cash from operations was a record $21.3 million, up $1.2 million compared with $20.1 million in the prior-year period. Total revenue for the full year 2014 was $335.1 million, an increase of $58.2 million, or 21%, compared with $276.8 million in 2013. GAAP operating income was $20.1 million, compared with $23.9 million in 2013. Non-GAAP operating income increased to $74.2 million, compared with $67.2 million in 2013. GAAP net income was $6.1 million, or $0.11 per diluted share, compared with $16.7 million, or $0.31 per diluted share, in 2013. Adjusted non-GAAP net income for the full year 2014 was $40.2 million, or $0.73 per diluted share, compared with $41.8 million, or $0.77 per diluted share, in 2013. Income before income taxes was $6.5 million against $18.4 million reported last year. Net cash provided by operating activities was $61.6 million against $69.6 million reported last year. Purchase of furniture, fixtures and equipment was $15.8 million against $30.5 million reported last year. EBITDA was a record $74.2 million, up 10% year-on-year. For the full year 2015, the company now expects revenues between $392.0 and $412.0 million, representing between 17% and 23% year-over-year growth. Non-GAAP operating income is expected to be between $90.0 and $96.0 million. Based on current estimates, this would equate to GAAP operating income between $33.0 and $35.5 million. Adjusted non-GAAP net income, which includes the tax affected adjustments primarily from stock-based compensation, non-cash interest expense associated with convertible senior notes and amortization at a 40% effective tax rate, between $47.0 and $50.5 million. Based on current estimates, this would equate to GAAP net income between $11.5 and $13.0 million. EBITDA for 2015 is expected to range from $90 million to $96 million, with margins of about 23%. Depreciation and amortization expense is expected to be about $12 million for the year. The company expects to spend about $20 million in CapEx. Taxes are expected to approximate 40%. For the first quarter of 2015, the company expects total revenue to grow in the range of 2% sequentially over fourth quarter of 2014 revenues. EBITDA margins are expected to be slightly higher than first quarter of 2014. The company expects first half of the year to represent a lower percentage of full year total revenues than historical trends would imply, with a greater quarterly ramp throughout the year of being a direct function of the size and quality of sales pipeline, as well as the timing of execution against this pipeline throughout the year. The company expects total revenues for the second half of 2015 to represent approximately 53.3% to 54.3% of full year revenue compared with 52.3% in 2014.

Medidata Solutions, Inc. Provides Earnings Guidance for the Year 2014

Medidata Solutions, Inc. provided earnings guidance for the year 2014. The company expects net revenue of $335.0 million to $340.0 million a year ago. Non-GAAP operating income expected to be $74.0 million to $76.0 million a year ago. Adjusted non-GAAP net income expected to be $38.0 million to $39.5 million, equivalent GAAP operating income expected to $18.5 million to $20.5 million, equivalent GAAP net income expected to be $3.0 million to $4.5 million a year ago. Effective tax rate expected to 38%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDSO:US $48.81 USD +0.70

MDSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Computer Programs & Systems Inc $52.86 USD +0.26
Enzo Biochem Inc $3.07 USD +0.01
HealthStream Inc $26.15 USD +0.27
Luminex Corp $16.09 USD +0.35
Merge Healthcare Inc $4.17 USD +0.17
View Industry Companies
 

Industry Analysis

MDSO

Industry Average

Valuation MDSO Industry Range
Price/Earnings 100.0x
Price/Sales 7.6x
Price/Book 9.6x
Price/Cash Flow 429.7x
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIDATA SOLUTIONS INC, please visit www.mdsol.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.